RT Journal
A1 Kuehn BM
T1 PEtition targets painkiller marketing in effort to curb overdose deaths
JF JAMA
JO JAMA
YR 2012
FD September 26
VO 308
IS 12
SP 1194
OP 1196
DO 10.1001/2012.jama.11248
UL http://dx.doi.org/10.1001/2012.jama.11248
AB 
As the number of deaths in the United States involving overdoses of prescription opioid medications continues a decade-long increase, a multidisciplinary group of clinicians is calling on the US Food and Drug Administration (FDA) to revise the labels of these drugs. They argue that aggressive marketing of painkillers for chronic noncancer pain has contributed to this ongoing public health crisis, despite limited evidence supporting the safety and efficacy of these medications for patients with chronic noncancer pain.